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Genetic controls  of immune  responses  to natural  and  synthetic antigens  are  ex- 
pressed by quantitative,  autosomal traits  (1).  A number of separate  dominant genes 
have been identified which regulate the ability of inbred strains  of mice and guinea 
pigs to elicit specific  immune responsesto  these imlnunogens  (2-13).  Although two 
genetic loci have been shown to be linked to histocompatibility regions of the mouse 
genome (12, 14, 15), little is known concerning the genetic mechanisms responsible for 
the control of immunity. In view of the number of complex cellular events required 
for immune processes,  it is likely that at least certain genetic controls will be demon- 
strable at the cellular level. In fact, responses of mice to synthetic polypeptides based 
on mulfichain polyalanine and  responses  of guinea pigs  to poly-L-lysine have been 
achieved by the injection of responder lymphoid cells  into irradiated  nonresponder 
animals (1, 14). Such transfer experiments suggest that these genetic defects reside in 
potentially immunocompetent cells,  although the nature of the cellular deficiency is 
not fully understood. Previous results indicate that the so-called "nonresponder" mice 
do produce small amounts of antibody to poly-L-(Tyr, Glu)-poly-L-Pro--poly-L-Lys, 
denoted (T, G)-Pro--L (10,  11). It is possible,  therefore, that the genetic defect in the 
low responder DBA/1  strain  could be attributed  to a  reduced number of immuno- 
competent precursor cells responsive to (T, G)-Pro--L when compared with the number 
in the high-responder SJL strain. 
The limiting dilution approach has been used to estimate immunocompetent 
precursor cell frequencies  by injecting  graded  and limiting  numbers  of spleen 
cells  into  irradiated  mice,  and  by  subsequently  analyzing  donor-derived  re- 
sponses in the recipients  (16-19).  The purpose of this investigation was to de- 
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termine  the  relative numbers  of  such  immunocompetent  precursors  in  spleen 
cell suspensions  of primed and normal high responder  and low responder  mouse 
strains  by  the limiting dilution method.  Results  of the present  study  indicate 
that spleen cell suspensions from immunized SJL donors contain about 25 times 
as many detectable precursors  as suspensions  from immunized DBA/1  donors. 
In cell suspensions  from normal spleens about 4  times more immunocompetent 
progenitors were detected in the SJL than in the DBA/1  strain.  Although pre- 
immunization increased  the number  of detectable precursors  in SJL donors by 
5-6 times, no effect on precursor number was observed for DBA/1  spleen cells. 
Materials and Methods 
Mice.--Inbred animals of both sexes,  10-13  wk of age,  were used as recipients, while fe- 
males of the same age were used as donors. DBA/1 mice were purchased  from  the  Jackson 
Laboratory,  Bar  Harbor,  Maine.  SJL  mice were  obtained from the Experimental Animal 
Unit, the Weizmann Institute of Science, and from the Jackson Laboratory. 
Immunization.--The immunogen  used  in  this  study was poly-L-(Tyr,  Glu)-poly-L-Pro-- 
poly-L-Lys,  701, denoted  (T,G)-Pro--L.  This is  a  branched  synthetic polymer built from 
multi-poly-L-prolyl--poly-L-lysine to whose polyproline side-chains short, random peptides of 
tyrosine and glutamic acid are attached.  Synthesis and characterization of this immunogen 
have  been  described  elsewhere  (20). Preimmunized spleen cell donors  were injected intra- 
dermally in  the hind footpads (according to standard  procedure [10]) with  10 #g of (T,  13)- 
Pro--L in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.) 3 wk before cell 
transfer.  Recipient mice received a  mixture of spleen cells from the preimmunized donors 
and 10#g of (T, G)-Pro-L intravenously in minimal essential medium of Eagle (Grand Island 
Biological Co., Grand Island, N. Y.).  Recipients injected with normal spleen cells were im- 
munized intraperitoneally with 10 #g of (T, G)-Pro--L in adjuvant,  1 day after cell transfer, 
to ensure exposure of the transferred immunocompetent cells to the immunogen. 
Irradiation.--Prospective recipient mice were exposed to 750-850 R  of whole body X-ir- 
radiation (250 kv peak, 15 ma, with 0.5 mm of Cu and 1.0 mm AI, source to target distance 50 
cm, and exposure rate of 60 R/rain) in a rotating lucite cage. 
Cell Suspensions and  Trar~splantatlon.--Spleen cells were  harvested  as  previously de- 
scribed (18). Nucleated cell counts were made by repeated sample counts using a hemocytom- 
eter. Injection of spleen cells into irradiated syngeneic recipients was  performed as described 
elsewhere  (18). 
Passive Microhemagglutinatlon Assay.--Sbeep  erythrocytes  were  formalinized,  tanned, 
and  coated with antigen as reported  (21).  Hemagglutinafion tests were performed on dis- 
posable microtiter plates  (Cooke Engineering Co., Alexandria, Va.)  by 2-fold  serial dilutions 
of antisera in phosphate-buffered saline (0.15 ~  NaC1, 0.01  ~  phosphate buffer,  pH 7) con- 
taining  0.1%  bovine plasma  albumin  (crystallized, Armour Pharmaceutical  Co.,  Chicago, 
Ill.). The plates were incubated at 20°C and read at 2.5 hr and overnight. 
Statistical Methods.--The Poisson model was used  to describe the theoretical probability 
that a known inoculum of donor-derived spleen cells would produce a  significant detectable 
amount of anti-(T,  G)-Pro--L serum in recipients (18).  The method of maximum likelihood 
as described by Porter and Berry (22) was used to estimate the probability values and 95% 
confidence  intervals. 
RESULTS 
Anti-(T,G)-Pro--L Responses in Control Mice.--In  order  to verify that  (T, 
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sufficient to prevent host-derived response, each experiment was accompanied 
by two types of controls. One group of intact (nonirradiated)  mice was primed 
at the time of donor immunization, and boosted 3 wk later at the time of im- 
munized spleen cell transfer.  Some of the above-mentioned animals were bled 
12-14 days after priming and their sera were tested. As shown in Table I, DBA/ 
1 mice responded to a single injection of (T, G)-Pro--L, although the titers were 
lower than those of SJL mice. Much larger differences were detected between 
DBA/1  and  SJL mice after a  second injection  of antigen.  Another  group of 
animals was irradiated  and injected only with  (T, G)-Pro--L in adjuvant.  No 
antibody was detected in 23 of 24 irradiated controls; a titer of 1 : 4 was detected 
in one animal. These results demonstrate that irradiation of the recipient ani- 
TABLE  I 
Anti-(T,G)-Pro--L  Titers in Control Animals 12-14 Days after Immunization 
Treatment of mice 
No. of sera with detectable  antibody 
and range of hemagglutination titers 
SJL  DBA/t 
Intact mice immunized only once 
Intact mice immunized and boosted 
Irradiated  mice*immunized  only once 
5/5  5/S 
1:32  1:16 
10/10  10/10 
1:64-1:256  1:8-1:16 
1/6  0/18 
0-1:4  0 
* Exposed to 750-850 R and given antigen without spleen cells. 
mals was sufficient to prevent host-derived responses. The sera of normal non- 
immunized mice were occasionally found to show antibody titers of 1:2-1:4. 
For these reasons only sera of irradiated  recipients  (injected with spleen cells 
and  antigen)  which reacted at  a  dilution  of 1:8 or higher were considered to 
contain a sufficient amount of antibody to be counted as positive. 
Frequency of Responses in Syngeneic Receipients Injected with Graded Numbers 
of Immunized SJL and DBA/1 Spleen  Cells.--Results of previous studies in- 
dicated that there is a significant difference between the level of the secondary 
anti-(T, G)-Pro--L response of SJL high responder and DBA/1  low responder 
mouse strains  (10,  11).  Therefore, it was of interest in this study to estimate 
first the frequencies of immunocompetent precursor cells reactive with (T, G)- 
Pro--L in spleens of immunized SJL and DBA/1 donors. 
In repeated experiments  124  SJL and  78  DBA/1  irradiated  recipient mice 
were injected with graded numbers (1.2  M  105-6.0  N  107) of spleen cells from 
immunized syngeneic donors. Antigen dissolved in Eagle's medium was injected 
simultaneously.  Recipients were bled from the retro-orbital sinus  at 2-3  day 
intervals between the 7th and 21st days after cell transfer. The greatest number 
of positive donor-derived responses in recipients and  the highest  anti-(T,G)- 616  GENETIC  CONTROL  OF  II~[UNE  RESPONSES 
Pro--L titers were obtained between days 11 and 13 in both mouse strains. This 
indicates that negative sera in DBA/1 recipients cannot be attributed to a de- 
TABLE II 
Percentage of Positive Sera in Irradiated Syngeneic Recipients 11-13 Days after Injection of 
(T, G)-Pro--L and Graded Numbers of SJL or DBA/1 Spleen Cells  from Immunized 
Donors 
No. of spleen  Fraction of  Percentage of  p  obabilit 
Strain of Mice  cells trans-  positive sera  positive sera  r  y  of positive  Precursor  cell 
planted  in recipients  m  recipients  sera per tO 6 celts*  frequency 
XIO  6  )<lO-e 
SJL  0.12  5/18  27.7 
0.25  7/19  36.8 
0.50  4/15  26.7 
1.0  11/18  61.1 
2.0  10/13  77.0 
4.0  16/18  89.0 
10.0  14/15  93.4 
50.0  8/8  100.0 
DBA/1 
0.79  1/1.26 
(0.55-0.89)2  (1/1.12-1/1.82)$ 
1.0  0/12  0 
10.0  6/13  46.2 
20.0  7/13  53.7  0.051  1/30 
40.0  18/25  72.0  (0.039-0.072)~  (1/22-1/46)~ 
60.0  15/15  100.0 
* Calculated according to reference 22. 
95% confidence intervals shown in parentheses. 
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FIG. 1. Percentage of  recipient mice with significant  anfi-(T,G)-Pro--L titers after in- 
jection of irradiated SJL and DBA/1  mice with graded numbers of immunized  syngeneic 
spleen cells and (T, G)-Pro--L. 
lay in anti-(T, G)-Pro--L response in the low responder strain. As the number 
of spleen cells injected increased, the proportion of recipients with positive sera 
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Approximately 60%  of SJL  sera  were found to be  positive  when  1  X  106 
spleen cells were injected. However, 54-72 %  of DBA/1 sera were positive only 
after  the  injection  of 2-4  X  10  ~ spleen  cells.  The inoculum size  required  for 
TABLE III 
Percentage of Positive Sera in Irradiated  Syngeneic Recipients 12-16  Days after Injection  of 
(T, G)-Pro--L and Graded Numbers of SJL or DBA/1 Spleen Cells  from Nonimmunized 
Donors 
No. of spleen  Fraction of  Percentage of  Probability of positive  Precursor  cell 
Strain of Mice  cells trans-  positive sera  positive sera 
planted  in recipients  in recipients  sera per lOS cells*  frequency 
XIO 6  XlO-6 
SJL  0.5  0/9  0 
1.0  2/9  22.1 
4.0  6/12  50.0 
10.0  7/11  63.6 
20.0  10/10  100.0 
DBA/1 
0.14  1/7.15 
(0.085-O.21)~  (1/4.76--1/11.8):~ 
5.0  1/4  25.0 
10.0  9/27  33.3 
20.0  6/12  50.0  0.032  1/31.3 
40.0  15/25  60.0  (0.022-0.045)~  (I/22.2-1/45.5) ~ 
60.0  10/10  100.0 
* Calculated according to reference 22. 
95% confidence intervals shown in parentheses. 
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FIG. 2. Percentage of recipient mice with significant anti-(T,  O)-Pro--L titers after injec- 
tion of irradiated  SJL and DBA/1 mice with graded numbers of nonimmunized syngeneic 
spleen ceils and (T, G)-Pro--L. 
two-thirds  of the  recipient  sera  to be positive  appeared  to be  20 to 40  times 
greater for I)BA/1 than for SJL immunized spleen cells (Table II). For a more 
precise evaluation,  the probability values that an inoculum of 106 spleen cells 
would produce a positive anti-(T, G)-Pro--L response after transfer were calcu- 618  GENETIC  CONTROL  OF  IMMUNE  RESPONSES 
lated for both mouse strains using the Poisson model (22). The value for im- 
munized SJL spleen cells was 24 times greater than that for DBA/1  cells. The 
difference in  these probability values was  statistically significant at  the 0.05 
level. The curves relating inoculum size to the expected frequency of positive 
sera in the recipients are shown in Fig.  1, together with the observed frequen- 
cies. One (T, G)-Pro--L sensitive precursor was detected in approximately 1.3 X 
l06 SJL (high responder) spleen cells, whereas one relevant precursor was found 
in about 30 X  106 DBA/I  (low responder) spleen cells. 
Frequency of Responses in Syngeneic  Recipienls  Injected with Graded Numbers 
of Normal SJL and DBA/1 Spleen Cells.--Since a large difference was detected 
between the precursor frequencies of spleen cells from SJL and DBA/1  mice, 
which were previously immunized with the synthetic antigen, it was of interest 
to  establish  whether  a  similar  difference could be  observed when  spleen cell 
suspensions from normal (nonimmunized) high and low responder mouse strains 
were compared. Graded and limiting numbers of SJL and DBA/1  spleen cells 
ranging from 5 X  105 to 6  X  107 were injected into a  total  of  129 irradiated 
syngeneic hosts.  One  day later  the recipients were  injected  intraperitoneally 
with antigen prepared in adjuvant.  Sera were tested for antibody 12,  14,  and 
16 days after immunization.  The limiting dilution results shown in Table III 
and Fig. 2 indicate a significant difference in the detected precursor frequencies 
for spleen cells from nonimmunized donors. Approximately 4.5  times as many 
antigen-sensitive precursors were detected in spleens of nonimmunized SJL as in 
spleens of nonimmunized DBA/1 mice. The probability values were statistically 
significant at the 0.05 level. The detected frequencies of precursor cells for SJL 
and DBA/1 spleens were about 1 in 7 X  106 and 1 in 31  X  106, respectively. 
DISCUSSION 
Previous studies of the genetic control of immune responses indicate that it 
is possible to transfer responsiveness to well-defined immunogens by transfer- 
ring high responder spleen cells,  fetal liver cells,  or peripheral blood lympho- 
cytes into irradiated low responder animals.  This has been interpreted to sug- 
gest that the genes controlling these immune responses act on a cell type directly 
involved in the process of antibody formation (1).  However, the  above-men- 
tioned studies have not established which cell type is responsible for the genetic 
deficiency nor the nature of this defect. The limiting dilution assay provides a 
method for approaching the elucidation of these problems. In the past, limiting 
dilution studies have been used successfully for estimating the relative number 
of precursor  cells  for heterologous erythrocyte antigens  (16-19).  The results 
presented here are the first to demonstrate that this approach can be applied 
equally well for studying the cellular basis of responses to synthetic polypeptide 
antigens. 
The experiments described indicate  that  there is  a  24-fold greater number EDNA  MOZES,  G.  M.  SHEARER,  AND  MICHAEL  SELA  619 
of anti-(T, G)-Pro--L precursor cells in spleens of immunized SJL mice, known 
to be high responders, than in those of immunized DBA/1  donors, which are 
low responders. This confirms results obtained with intact animals, indicating 
that the genetic defect is quantitative (references 10 and 11, and Table I), and 
demonstrates that the low response of DBA/1  can be attributed to a striking 
reduction in the number of detected precursor cells. Furthermore, a significant 
4.5-fold  difference was  observed in  the  number  of  splenic  antigen-sensitive 
precursors form nonimmunized donors, suggesting that the defect is expressed 
even before immunization.  The differences observed cannot be  attributed  to 
different temporal patterns of antibody production because the highest titers 
were obtained between days  11  and  13  in both mouse strains.  The contrast 
between high and low responder animals was more pronounced when they were 
compared by the criterion of the number of antigen-sensitive precursor cells 
than by the criterion of the amount of antibodies produced in the intact mice 
(references 10 and  11,  and Table I). The differences found between SJL and 
DBA/1 precursor frequencies for normal and immunized spleen cells were 4.5- 
fold and 24-fold, respectively, whereas the differences in titers of intact mice 
were only 2-fold and 8- to 16-fold. It might thus be difficult to find a significant 
difference between the antibody titers of genetically different strains of mice 
after a single injection of a synthetic antigen (23). Since genetic controls of some 
immune responses are expressed by quantitative differences, we have chosen to 
refer to SJL and DBA/1  as high responder and low responder strains,  respec- 
tively,  rather  than  the  previous  nomenclature  of  "responder"  and  "nonre- 
sponder" used in genetic studies of this type (1-14). 
The limiting dilution experiments give estimates only of the number of de- 
tected precursors. It could thus be argued that the genetic defect may involve 
differences in affinity of precursor cells, and does not necessarily indicate differ- 
ences in total numbers of relevant cells.  Should this be the case, these results 
would still point to significant differences in the frequencies of "high affinity 
precursors" in high and low responder mouse strains. 
A  more thorough understanding of the molecular and cellular basis  of im- 
munological processes will require a  detailed systematic investigation of the 
complex events  associated  with  genetic control of immunity  to well-defined 
synthetic antigens. For certain natural antigens formation of specific antibodies 
has been shown to require two and perhaps even three distinct cell types (24- 
31). The roles of these various cells are unknown, but they include recognition 
of  antigenic  determinants  and  production  of  antibodies.  Functionally,  the 
cooperating cells can be integrated into an antigen-sensitive unit (32). Genetic 
controls of such a complex series of events could be expressed at any of these 
and/or other levels. For example, separate gene loci have been found to regulate 
immune responses of mice to (Phe, G)-Pro--L (11). Control of the response to 
the (Phe, G) portion of the molecule is linked to H-2, whereas that of the re- 620  GENETIC  CONTROL  OF  IMMUNE  RESPONSES 
sponse to the  (Pro--L) part is not.  The same population of precursor cells in 
SJL mice appears to respond to (Pro--L) independently of whether the immun- 
ogen is (T,  G)-Pro--L or (Phe, G)-Pro--L, and suggests that separate cell pop- 
ulations are  reactive  with  the  (Phe, G)  and  (Pro--L)  portions  of  the  mol- 
ecule  (Mozes, Shearer, and Sela,  unpublished data). 
The spleen contains a very heterogeneous population of cells, and the experi- 
ments described in the present report were not designed to establish in which 
functional cell type the genetic defect is expressed. Unpublished results (Shearer, 
Mozes, and Sela) indicate that cooperation between thymus-derived and mar- 
row-derived cells is necessary for the anti-(T, G)-Pro--L response in mice. There- 
fore, it will be possible, by thymus-marrow cell transfer experiments, to deter- 
mine in which  immunocompetent cell  population genetic control to  this im- 
munogen is expressed. 
SUMMARY 
SJL mice are high responders to the synthetic multichain polypeptide antigen 
(T,G)-Pro--L, whereas DBA/1  mice are low responders (10,  11).  In order to 
determine whether the genetic control of immune response  can be  correlated 
with  the number of antigen-sensitive precursor cells,  spleen  cell suspensions 
from normal and immunized SJ-L and DBA/1  donor mice were transplanted 
into lethally X-irradiated syngeneic recipients (incapable of immune response) 
along with  (T,G)-Pro--L. Anti-(T,G)-Pro--L responses  (donor-derived) were 
assayed in the sera of the hosts 12-16 days later. By transplanting graded and 
limiting numbers of spleen cells,  inocula were found which contained one or a 
few  antigen-sensitive  precursors  reactive  with  the  immunogen.  Using  this 
method to estimate the relative numbers of such cells for the high responder 
SJL strain, one precursor was detected in ~-d.3  X  106 and ~7.2  X  106 spleen 
cells  from immunized  and normal donors,  respectively. In contrast,  one pre- 
cursor was detected in about 30 >(  l06 spleen cells from low responder DBA/1 
mice, irrespective of whether the donors had been immunized. 
These results indicate that the genetic control of immunity to the synthetic 
polypeptide antigen investigated is directly correlated to the relative number 
of  precursor  cells  reactive with  the  immunogen  in  high  and  low  responder 
strains. 
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